Latest filing published 05 Oct 2017 for Kite Pharma, Inc.. Read the official filing
All filings by Farah Champsi on record concern Kite Pharma, Inc. The record holds 17 filings, for trades running from 1 June 2016 to 3 October 2017.
Every open-market trade on record is a sale: 12 sales worth €21.4M. The rest of the record consists of 2 share grants. In 2017 alone, the filings show no purchases and 12 sales.
Most recently, on 5 October 2017, the filings show a transaction in Kite Pharma, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations